Bayer | BAYN - Net Income


Bayer reported EUR2.76B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Air Liquide EUR 1.82B 105.8M Jun/2026
Akzo Nobel EUR 139M 46M Jun/2026
Alcon AG USD 189M 28M Mar/2026
Amarin USD -1.22M 6.51M Dec/2025
Arkema EUR 65.7M 38.5M Jun/2026
AstraZeneca USD 2.51B 573M Jun/2026
BASF EUR 4.14B 3.22B Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
Corteva USD 1.16B 441M Jun/2026
Covestro EUR -378M 331M Dec/2025
Essilor EUR 1.57B 638M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 303M 250M Jun/2026
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Henkel EUR 988M 63M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -78M 60M Jun/2026
Linde USD 1.86B 327M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.26B 108M Jun/2026
Nutrien USD 1.21B 1.08B Jun/2026
Philips EUR 384M 233M Jun/2026
PPG Industries USD 437M 55M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
SAP EUR 2.21B 277M Jun/2026
Solvay EUR 38M 12M Jun/2026
UCB EUR 1.08B 608M Dec/2025
Umicore EUR 239.8M 8.05M Jun/2026
Vinci EUR 2.08B 929M Jun/2026